Literature DB >> 16413396

In vitro transdifferentiation of adult bone marrow Sca-1+ cKit- cells cocultured with fetal liver cells into hepatic-like cells without fusion.

Yasuhiro Yamada1, Eishi Nishimoto, Hiroaki Mitsuya, Yuji Yonemura.   

Abstract

Several research groups have recently reported that certain bone marrow cells (BMCs) differentiate into hepatocytes in vitro as well as in vivo in rodents. However, it has yet to be elucidated what factors effectively trigger and sustain transdifferentiation of BMCs. In the present study, we specifically asked whether the presence of murine fetal liver cells (FLCs) triggered and supported in vitro transdifferentiation of murine BMCs. Fractionated BMCs from green fluorescence protein (GFP)-expressing transgenic mice and FLCs from ROSA26 mice (X-gal(+) FLCs) were cocultured in the presence of hepatocyte growth factor in laminin-coated dishes. We found that Sca-1(+) BMCs gave rise to adherent hepatic-like cells, which expressed albumin as assessed with immunocytochemistry and RNA-polymerase chain reaction (PCR), and alpha-fetoprotein and cytokeratin 19 as examined with RNA-PCR. When GFP(+)Sca-1(+)cKit(-) cells were cocultured with X-gal(+) FLCs, all GFP(+) albumin-producing cells were negative for X-gal, showing that cell fusion was not associated in the observed BMCs' differentiation into hepatic-like cells. Titration analysis revealed that 1 of 5,943 Sca-1(+)cKit(-) cells had the ability to proliferate and differentiate into hepatic-like cells. These data strongly suggest that BMCs differentiate into hepatic-like cells in the presence of FLCs and that the present method may be useful for propagating BMC-derived hepatocytic progenitors and for investigating the nature of those cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16413396     DOI: 10.1016/j.exphem.2005.09.018

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  8 in total

Review 1.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

2.  Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells.

Authors:  P A Lysy; D Campard; F Smets; J Malaise; M Mourad; M Najimi; E M Sokal
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

3.  Stem cells, phenotypic inversion, and differentiation.

Authors:  Robert W Siggins; Ping Zhang; David Welsh; Nicole J Lecapitaine; Steve Nelson
Journal:  Int J Clin Exp Med       Date:  2008-01-20

Review 4.  Stem cells for end stage liver disease: how far have we got?

Authors:  Stefania Lorenzini; Stefano Gitto; Elena Grandini; Pietro Andreone; Mauro Bernardi
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 5.  Activation of stem cells in hepatic diseases.

Authors:  T G Bird; S Lorenzini; S J Forbes
Journal:  Cell Tissue Res       Date:  2007-11-29       Impact factor: 5.249

6.  Murine Sca1(+)Lin(-) bone marrow contains an endodermal precursor population that differentiates into hepatocytes.

Authors:  Keunhee Oh; Suh Youn Shon; Myung Won Seo; Hak Mo Lee; Ju-Eun Oh; Eun Young Choi; Dong-Sup Lee; Kyong Soo Park
Journal:  Exp Mol Med       Date:  2015-10-02       Impact factor: 8.718

7.  Analysis of epithelial-mesenchymal transition markers in the histogenesis of hepatic progenitor cell in HBV-related liver diseases.

Authors:  Wei Xu; Nong-Rong Wang; Hua-Feng Wang; Qiong Feng; Jun Deng; Zhi-Qiang Gong; Jian Sun; Xiao-Liang Lou; Xue-Feng Yu; Lv Zhou; Jin-Ping Hu; Xiao-Feng Huang; Xiao-Qing Qi; Yan-Juan Deng; Rui Gong; Yan Guo; Meng-Meng Wang; Jia-Cheng Xiao; Huan Deng
Journal:  Diagn Pathol       Date:  2016-11-24       Impact factor: 2.644

Review 8.  Cellular Mechanisms of Liver Regeneration and Cell-Based Therapies of Liver Diseases.

Authors:  Irina V Kholodenko; Konstantin N Yarygin
Journal:  Biomed Res Int       Date:  2017-01-22       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.